![Preoperative CA-125 Value as a Predictive Factor for Postoperative Outcome in First Relapse of Platinum-sensitive Serous Ovarian Cancer | Anticancer Research Preoperative CA-125 Value as a Predictive Factor for Postoperative Outcome in First Relapse of Platinum-sensitive Serous Ovarian Cancer | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/38/8/4865/F1.large.jpg)
Preoperative CA-125 Value as a Predictive Factor for Postoperative Outcome in First Relapse of Platinum-sensitive Serous Ovarian Cancer | Anticancer Research
![Illustration of antigen capture–based assays for CA125 free antigen and... | Download Scientific Diagram Illustration of antigen capture–based assays for CA125 free antigen and... | Download Scientific Diagram](https://www.researchgate.net/publication/47414767/figure/fig1/AS:339632244969481@1457986045930/Illustration-of-antigen-capture-based-assays-for-CA125-free-antigen-and-CA125-in-immune.png)
Illustration of antigen capture–based assays for CA125 free antigen and... | Download Scientific Diagram
![Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | SpringerLink Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12282-020-01058-3/MediaObjects/12282_2020_1058_Fig2_HTML.png)
Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | SpringerLink
![Prognostic and predictive value of combined HE-4 and CA-125 biomarkers during chemotherapy in patients with epithelial ovarian cancer - Enrico Potenza, Giulia Parpinel, Maria E. Laudani, Chiara Macchi, Luca Fuso, Paolo Zola, Prognostic and predictive value of combined HE-4 and CA-125 biomarkers during chemotherapy in patients with epithelial ovarian cancer - Enrico Potenza, Giulia Parpinel, Maria E. Laudani, Chiara Macchi, Luca Fuso, Paolo Zola,](https://journals.sagepub.com/cms/10.1177/1724600820955195/asset/images/large/10.1177_1724600820955195-fig2.jpeg)
Prognostic and predictive value of combined HE-4 and CA-125 biomarkers during chemotherapy in patients with epithelial ovarian cancer - Enrico Potenza, Giulia Parpinel, Maria E. Laudani, Chiara Macchi, Luca Fuso, Paolo Zola,
![Nadir CA-125 has prognostic value for recurrence, but not for survival in patients with ovarian cancer | Scientific Reports Nadir CA-125 has prognostic value for recurrence, but not for survival in patients with ovarian cancer | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-97564-1/MediaObjects/41598_2021_97564_Fig1_HTML.png)
Nadir CA-125 has prognostic value for recurrence, but not for survival in patients with ovarian cancer | Scientific Reports
![JCM | Free Full-Text | CA125 as a Marker of Heart Failure in the Older Women: A Population-Based Analysis JCM | Free Full-Text | CA125 as a Marker of Heart Failure in the Older Women: A Population-Based Analysis](https://pub.mdpi-res.com/jcm/jcm-08-00607/article_deploy/html/images/jcm-08-00607-g002.png?1571479883)
JCM | Free Full-Text | CA125 as a Marker of Heart Failure in the Older Women: A Population-Based Analysis
![Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13048-020-00681-0/MediaObjects/13048_2020_681_Fig3_HTML.png)
Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text
![CA125, YKL-40, HE-4 and Mesothelin: a new serum biomarker combination in discrimination of benign and malign epithelial ovarian tumor CA125, YKL-40, HE-4 and Mesothelin: a new serum biomarker combination in discrimination of benign and malign epithelial ovarian tumor](https://www.degruyter.com/document/doi/10.1515/tjb-2019-0038/asset/graphic/j_tjb-2019-0038_fig_005.jpg)
CA125, YKL-40, HE-4 and Mesothelin: a new serum biomarker combination in discrimination of benign and malign epithelial ovarian tumor
![Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13048-020-00681-0/MediaObjects/13048_2020_681_Fig4_HTML.png)
Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text
![CA125 as a predictor of endometrial cancer lymphovascular space invasion and lymph node metastasis for risk stratification in the preoperative setting | Scientific Reports CA125 as a predictor of endometrial cancer lymphovascular space invasion and lymph node metastasis for risk stratification in the preoperative setting | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-22026-1/MediaObjects/41598_2022_22026_Fig1_HTML.png)
CA125 as a predictor of endometrial cancer lymphovascular space invasion and lymph node metastasis for risk stratification in the preoperative setting | Scientific Reports
![Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13048-020-00681-0/MediaObjects/13048_2020_681_Fig5_HTML.png)
Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text
![Actual ROC curves for CA 125 assays [pretreatment ovarian cancer (n 46)... | Download Scientific Diagram Actual ROC curves for CA 125 assays [pretreatment ovarian cancer (n 46)... | Download Scientific Diagram](https://www.researchgate.net/publication/13620311/figure/fig2/AS:601615283277853@1520447669409/Actual-ROC-curves-for-CA-125-assays-pretreatment-ovarian-cancer-n-46-vs-benign-pelvic.png)
Actual ROC curves for CA 125 assays [pretreatment ovarian cancer (n 46)... | Download Scientific Diagram
![Clinical significance and diagnostic value of serum NSE, CEA, CA19‑9, CA125 and CA242 levels in colorectal cancer Clinical significance and diagnostic value of serum NSE, CEA, CA19‑9, CA125 and CA242 levels in colorectal cancer](https://www.spandidos-publications.com/article_images/ol/20/1/ol-20-01-0742-g01.jpg)
Clinical significance and diagnostic value of serum NSE, CEA, CA19‑9, CA125 and CA242 levels in colorectal cancer
Cell-free tumor DNA, CA125 and HE4 for the objective assessment of tumor burden in patients with advanced high-grade serous ovarian cancer | PLOS ONE
![Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13048-020-00681-0/MediaObjects/13048_2020_681_Fig1_HTML.png)